Contacts Are Where It’s At

by

The true purpose of the PharmSource Lead Sheet is to keep you abreast of any event that would create an opportunity for a service or product provider in the drug, device or diagnostic development arena. In order to create this weekly business development tool we track drugs from discovery through to marketed, alert you to […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AveXis, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AveXis, Inc., develops gene therapies for the treatment of rare and orphan neurological genetic diseases. It plans to raise $234.5 million in a secondary public […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Titan Medical, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Titan Medical, Inc. is a public company based in Canada that designs and develops robotic surgical systems for applications […]

Learn more

Contract Manufacturing Through the Years

by

How has the bio/pharmaceutical contract manufacturing industry evolved over the years and what does the future hold? The 40 years during which Pharmaceutical Technology has served the bio/pharmaceutical industry have been years of momentous growth and change in the way drugs are discovered, developed, manufactured, and sold. Contract development and manufacturing organizations (CDMOs) have long […]

Learn more

AMRI Sold to PE Firms

by

Albany Molecular Research Inc. (AMRI) is being taken private in a deal that values the company at $922 million. The buyers, private equity firms The Carlyle Group and GTCR, are newcomers to the contract development and manufacturing organization (CDMO) space, although Carlyle also owns clinical contract research organization (CRO) PPD Inc. The investors are paying […]

Learn more

Growing Mexico Is Home to Solid CMO Population

by

Proximity to the US, a strong regulatory scheme, affordability and decades-long relationships forged with the help of the North American Free Trade Agreement (NAFTA) are among the factors that may make Mexico an attractive location for contract manufacturing services, particularly for products sold in the US or Latin American markets. The country is also fairly […]

Learn more

PharmSource Coverage of ASCO 2017

by

Chicago hosted 30,000 American Society of Clinical Oncology (ASCO) conference visitors this weekend, including myself and fellow researcher Scotty Chung-Siu. You may have noticed the uptick in the PharmSource Lead Sheet recently, especially in Phase I & II studies. In fact, oncology leads hold 46% of this week’s PharmSource Lead Sheet, so be sure to […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on AmpliPhi Biosciences Corporation

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AmpliPhi Biosciences, (formerly known as Targeted Genetics Corporation), develops gene-based products for the treatment of acquired and inherited diseases. It raised $9.1 million in a […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on CartiHeal Ltd.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. CartiHeal Ltd. is a private company based in Israel that develops cell-free cartilage regeneration technology. It raised $18.3 million […]

Learn more